ID
43641
Description
Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies; ODM derived from: https://clinicaltrials.gov/show/NCT00050687
Link
https://clinicaltrials.gov/show/NCT00050687
Keywords
Versions (2)
- 6/4/16 6/4/16 -
- 9/20/21 9/20/21 -
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Prostatic Neoplasms NCT00050687
Eligibility Prostatic Neoplasms NCT00050687
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Weight loss
Data type
boolean
Alias
- UMLS CUI [1]
- C1262477
Description
active serious infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
bisphosphonates
Data type
boolean
Alias
- UMLS CUI [1]
- C0012544
Description
participation in other research
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Description
brain metastasis
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
Description
intrathecal chemotherapy or whole-brain radiotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C1517560
- UMLS CUI [2]
- C1520143
Description
compliance behavior
Data type
boolean
Alias
- UMLS CUI [1]
- C1321605
Description
other malignancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Description
optic neuritis
Data type
boolean
Alias
- UMLS CUI [1]
- C0029134
Description
diuretics
Data type
boolean
Alias
- UMLS CUI [1]
- C0012798
Similar models
Eligibility Prostatic Neoplasms NCT00050687
- StudyEvent: Eligibility
C0278620 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0231921 (UMLS CUI [4])
C1520143 (UMLS CUI [2])